Repository logo
 

Comment on Herring et al. The Use of "Retardation" in FRAXA, FMRP, FMR1 and Other Designations. Cells 2022, 11, 1044.

Published version
Peer-reviewed

Type

Article

Change log

Authors

On Behalf Of The Hugo Gene Nomenclature Committee Hgnc 

Abstract

This commentary is written in response to the recent article from Herring et al., discussing the eradication of the offensive term "retardation" from gene nomenclature. We discuss the work of the HUGO (Human Genome Organisation) Gene Nomenclature Committee (HGNC) and outline the steps already taken to remove this term from our gene names. We also highlight the latest nomenclature changes made as a result of discussions with the authors and agreement with the European Fragile X Network.

Description

Keywords

FMR1, FRAXA, HGNC, fragile X syndrome, gene nomenclature, Fragile X Mental Retardation Protein, Fragile X Syndrome, Humans

Journal Title

Cells

Conference Name

Journal ISSN

2073-4409
2073-4409

Volume Title

11

Publisher

MDPI AG
Sponsorship
NHGRI NIH HHS (U24 HG003345)
Wellcome Trust (208349/Z/17/Z)